HZNP - Horizon Pharma Public Limited Company

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
14.14
+0.31 (+2.24%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close13.83
Open13.79
Bid0.00 x 0
Ask0.00 x 0
Day's Range13.60 - 14.18
52 Week Range9.45 - 21.98
Volume1,836,640
Avg. Volume3,450,753
Market Cap2.31B
Beta0.57
PE Ratio (TTM)-5.23
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube9 days ago

    ETFs with exposure to Horizon Pharma Plc : October 11, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Horizon Pharma Plc Here are 5 ETFs with the largest exposure to HZNP-US. Comparing the performance and risk of Horizon Pharma Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Horizon Pharma Plc breached its 50 day moving average in a Bullish Manner : HZNP-US : October 3, 2017
    Capital Cube17 days ago

    Horizon Pharma Plc breached its 50 day moving average in a Bullish Manner : HZNP-US : October 3, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Horizon Pharma Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish ... Read more (Read more...)

  • Horizon Pharma Public Limited Company (HZNP): How Does It Impact Your Portfolio?
    Simply Wall St.17 days ago

    Horizon Pharma Public Limited Company (HZNP): How Does It Impact Your Portfolio?

    If you are a shareholder in Horizon Pharma Public Limited Company’s (NASDAQ:HZNP), or are thinking about investing in the company, knowing how it contributes to the risk and reward profileRead More...

  • Capital Cube23 days ago

    ETFs with exposure to Horizon Pharma Plc : September 27, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Horizon Pharma Plc Here are 5 ETFs with the largest exposure to HZNP-US. Comparing the performance and risk of Horizon Pharma Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Is Horizon Pharma (HZNP) A Suitable Pick for Value Investors?
    Zacks29 days ago

    Is Horizon Pharma (HZNP) A Suitable Pick for Value Investors?

    Let's find out if Horizon Pharma Public Limited Company (HZNP) stock is a good choice for value-oriented investors right now

  • Reuterslast month

    Horizon Pharma weighs sale of primary care unit -sources

    Specialty drugmaker Horizon Pharma PLC is working with investment bank Morgan Stanley to review strategic options for its primary care drugs business, including a potential sale of the unit, people familiar with the matter said on Friday. Dublin-based Horizon is in talks with a number of parties interested in acquiring the asset, expected to generate annual revenue of $350 million in sales in 2017, according to the people, who asked not to be named because the discussions are private. Horizon declined to comment.

  • Horizon Pharma Plc breached its 50 day moving average in a Bearish Manner : HZNP-US : September 14, 2017
    Capital Cubelast month

    Horizon Pharma Plc breached its 50 day moving average in a Bearish Manner : HZNP-US : September 14, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Horizon Pharma Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish ... Read more (Read more...)

  • Capital Cubelast month

    ETFs with exposure to Horizon Pharma Plc : September 13, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Horizon Pharma Plc Here are 5 ETFs with the largest exposure to HZNP-US. Comparing the performance and risk of Horizon Pharma Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Horizon Pharma Plc :HZNP-US: Earnings Analysis: Q2, 2017 By the Numbers : September 11, 2017
    Capital Cubelast month

    Horizon Pharma Plc :HZNP-US: Earnings Analysis: Q2, 2017 By the Numbers : September 11, 2017

    Categories: Yahoo FinanceGet free summary analysis Horizon Pharma Plc reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Horizon Pharma Plc – Amgen Inc., Aralez Pharmaceuticals Inc., Dr. Reddy’s Laboratories Ltd. Sponsored ADR, Radius Health Inc, Alder Biopharmaceuticals, Inc., Astrazeneca PLC Sponsored ADR, Merck & Co., ... Read more (Read more...)

  • See what the IHS Markit Score report has to say about Horizon Pharma PLC.
    Markitlast month

    See what the IHS Markit Score report has to say about Horizon Pharma PLC.

    Short interest is low for HZNP with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.

  • Capital Cube2 months ago

    Horizon Pharma Plc – Value Analysis (NASDAQ:HZNP) : August 21, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Horizon Pharma Plc a score of 22. Our analysis is based on comparing Horizon Pharma Plc with the following peers – Amgen Inc., Aralez Pharmaceuticals Inc., Dr. Reddy’s Laboratories Ltd. Sponsored ADR, Radius Health Inc, Alder Biopharmaceuticals, Inc., Astrazeneca PLC Sponsored ADR, Merck & Co., Inc., BioSpecifics ... Read more (Read more...)

  • Horizon Pharma (HZNP) Soars: Stock Adds 10.5% in Session
    Zacks2 months ago

    Horizon Pharma (HZNP) Soars: Stock Adds 10.5% in Session

    Horizon Pharma Public Limited Company (HZNP) was a big mover last session, as the company saw its shares rise nearly 11% on the day amid huge volumes.

  • Here's Why Horizon Pharma Gained as Much as 13.1% Today
    Motley Fool2 months ago

    Here's Why Horizon Pharma Gained as Much as 13.1% Today

    The biopharma successfully staved off a generic challenger for its most important drug.

  • See what the IHS Markit Score report has to say about Horizon Pharma PLC.
    Markit2 months ago

    See what the IHS Markit Score report has to say about Horizon Pharma PLC.

    Short interest is low for HZNP with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. ETFs that hold HZNP had net inflows of $560 million over the last one-month.

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of HZNP earnings conference call or presentation 7-Aug-17 12:00pm GMT

    Q2 2017 Horizon Pharma PLC Earnings Call

  • IHS Markit Score upgrades Horizon Pharma PLC to 40 out of 100, despite ranking positively in only one IHS Markit category.
    Markit2 months ago

    IHS Markit Score upgrades Horizon Pharma PLC to 40 out of 100, despite ranking positively in only one IHS Markit category.

    Short interest is low for HZNP with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last one-month, outflows of investor capital in ETFs holding HZNP totaled $208 million.

  • Horizon Pharma Plc breached its 50 day moving average in a Bearish Manner : HZNP-US : August 10, 2017
    Capital Cube2 months ago

    Horizon Pharma Plc breached its 50 day moving average in a Bearish Manner : HZNP-US : August 10, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Horizon Pharma Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish ... Read more (Read more...)

  • IHS Markit Score downgrades Horizon Pharma PLC to 30 out of 100, ranking positively in only one out of three available IHS Markit categories.
    Markit2 months ago

    IHS Markit Score downgrades Horizon Pharma PLC to 30 out of 100, ranking positively in only one out of three available IHS Markit categories.

    Short interest is low for HZNP with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last one-month, outflows of investor capital in ETFs holding HZNP totaled $557 million.

  • Horizon Pharma (HZNP) Q2 Earnings & Sales Top, Raises View
    Zacks2 months ago

    Horizon Pharma (HZNP) Q2 Earnings & Sales Top, Raises View

    Horizon Pharma plc (HZNP) topped both earnings and sales estimate in second-quarter 2017 and raised its sales guidance for 2017.

  • Associated Press2 months ago

    Horizon Pharma reports 2Q loss

    The Dublin-based company said it had a loss of $1.29 per share. Earnings, adjusted for non-recurring costs, were 41 cents per share. The results surpassed Wall Street expectations. The average estimate ...

  • Horizon Pharma PLC (HZNP) Q2 Report Sends Shares Surging
    InvestorPlace2 months ago

    Horizon Pharma PLC (HZNP) Q2 Report Sends Shares Surging

    This is a drop from its earnings per share of 56 cents from the same time last year. Revenue of $289.50 million in the second quarter of the year was also good news for HZNP stock. It comes in higher than Horizon Pharma PLC’s revenue of $257.40 million from the second quarter of 2016.

  • TheStreet.com2 months ago

    Energy Losses Put Dow's Record-Breaking Streak in Jeopardy

    The Dow could close with its ninth day of records.

  • 24/7 Wall St.2 months ago

    Horizon Pharma Wins Big in Q2

    Horizon Pharma released a better than expected quarterly earnings report before the markets opened on Monday.

  • Why Horizon Pharma plc Stock Is Rising Today
    Motley Fool2 months ago

    Why Horizon Pharma plc Stock Is Rising Today

    Horizon Pharma may be getting back on track after a strong second quarter.

  • The Wall Street Journal2 months ago

    Stocks to Watch: Brighthouse, Berkshire Hathaway, Tesla, Horizon Pharma

    Among the companies with shares expected to trade actively in Monday's session are Brighthouse Financial Inc., Berkshire Hathaway Inc., Tesla Inc. and Horizon Pharma PLC.